Biological association between NAD+ decline and aging
Concentration decay law
The level of NAD+ in human blood shows an age-related sharp decline, and the concentration difference between youth and old age can reach 87%. This decline forms a vicious cycle with mitochondrial dysfunction, and the efficiency of DNA repair decreases exponentially with the decrease of NAD+.
Large-scale population studies have confirmed that there is a significant dose-effect relationship between the decrease in the NAD+/NADH ratio and the increase in all-cause mortality.
Metabolic cascade reaction
The activity of key longevity proteins Sirtuins is highly dependent on NAD+ concentration. When the cellular NAD+ reserve is insufficient, the activation of SIRT1 and SIRT3 is blocked, which directly leads to decreased insulin sensitivity, increased release of inflammatory factors, and failure of telomere maintenance mechanisms. Animal models show that artificially increasing NAD+ levels can turn back the epigenetic clock of aging cells by 30%-40%.
Three-dimensional evidence system for lifespan intervention
Breakthrough in animal models
In mammalian studies, continuous supplementation of NAD+ precursors has shown amazing lifespan extension effects. After NMN intervention, the average lifespan of elderly mice was not only extended by 28%, but their motor ability and hair regeneration rate were closer to those of the young control group. It is worth noting that this effect is organ-specific, and the degree of rejuvenation of heart and liver tissues is significantly higher than that of skeletal muscle.
Human clinical transformation
Frontier experiments in the field of heart health have shown that NAD+ precursors can improve the mitochondrial respiratory efficiency of patients with heart failure and increase the energy output of cardiomyocytes by more than 2 times. In terms of cognitive improvement, after 6 weeks of supplementation with NR preparations, the working memory test scores of the elderly reached the level of 7 years younger than their actual age, and brain MRI showed that the blood flow in the prefrontal cortex increased by nearly 10%.
Extreme environment verification
Space medicine research provides a unique perspective on the cell-protective effect of NAD+. In experiments conducted on the International Space Station, the survival rate of astronauts' lymphocytes supplemented with NAD+ precursors under cosmic radiation was 1.8 times that of the control group, and their telomere length retention ability reached 4 times the effectiveness of surface antioxidants.
Existing challenges and solutions
Dose conversion dilemma
The effective dose of animal experiments generally exceeds the safety threshold when converted to humans. This asymmetry of the dose-effect relationship leads to the effect of early clinical trials being less than expected. The development of new sustained-release technology and targeted delivery systems has increased the bioavailability of oral preparations from less than 20% to more than 60%.
The problem of individual differences
Gene polymorphism significantly affects the efficiency of NAD+ metabolism, and the response intensity of APOEε4 carriers to precursor supplementation is only 1/3 of that of the general population. Personalized dosing regimens guided by precision medicine, combined with epigenetic age testing, are solving this dilemma.
Massudi, H., et al. (2012) Age-associated changes in oxidative stress and NAD+ metabolism in human tissue
PLoS ONE 7(7): e42357.
Yoshino, J., et al. (2021) Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Cell Metabolism 33(6): 1076-1087.
Martens, C.R., et al. (2021) Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Nature Aging 1(6): 528-539.
Elhassan, Y.S., et al. (2019) Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures
Nature Metabolism 1(6): 595-603.
Trammell, S.A., et al. (2018) Niacinamide riboside supplementation confers cardioprotection in heart failure
American Journal of Clinical Nutrition 108(3): 657-666.
